Hydroxyurea-induced dermatomyositis-like eruption

Journal of the American Academy of Dermatology

Volumn 48, Issue 3, 2003, Pages 439-441

  Dacey, Michael J ^a   Callen, Jeffrey P ^a,b  

^a University of Louisville School of Medicine   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYUREA; MUCIN;

AGED; ARTICLE; CASE REPORT; CHRONIC MYELOID LEUKEMIA; DERMATOMYOSITIS; DRUG ERUPTION; FEMALE; HUMAN; HYPERPIGMENTATION; LEG ULCER; LUPUS ERYTHEMATOSUS; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RASH; SKIN BIOPSY;

EID: 0037339920     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1067/mjd.2003.74     Document Type: Article

References (21)

1. Vassalo C, Passamonti F, Merante S, Ardigo M, Nolli G, Mangiacavalli S, et al. Mucocutaneous changes during long-term therapy with hydroxurea in chronic myeloid leukaemia. Clin Exp Dermatol 2001;26:141-8.
2. Senet P, Aractingi S, Porneuf M, Perrin P, Duterque M. Hydroxyurea induced dermatomyositis like eruption. Br J Dermatol 1995; 133:455-9.
3. Marie I, Joly P, Levesque H, Heron F, Courville P, Cailleux N, et al. Pseudo-dermatomyositis as a complication of hydroxyurea therapy. Clin Exp Rheumatol 2000;18:536-7.
4. Bahadoran P, Castanet J, Lacour JP, Perrin C, Del Giudice P, Mannocci N, et al. Pseudo-dermatomyositis induced by long-term hydroxyrea therapy: report of two cases. Br J Dermatol 1996;134:1161-3.
5. Daoud MS, Gibson LE, Pittelkow MR. Hydroxyurea dermopathy: a unique lichenoid eruption complicating long-term therapy with hydroxyurea. J Am Acad Dermatol 1997;3:178-82.
6. Suehiro M, Kishimoto S, Wakabayashi T, Ikeuchi A, Miyake H, Takenaka H, et al. Hydroxyurea dermatopathy with a dermatomyositis-like eruption and a large leg ulcer. Br J Dermatol 1998;139:748-9.
7. Sigal M, Crickx B, Blanchet P, Perron J, Simony J, Belaich S. [Cutaneous lesions induced by long-term use of hydroxyurea.] Ann Dermatol Venereol 1984;111:895-900. French.
8. Burns DA, Sarkany I, Gaylarde P. Effects of hydroxyurea therapy on normal skin: a case report. Clin Exp Dermatol 1980;5:447-9.
9. Chantereau MJ, Lorcerie B, Escallier F. L'hydroxyuree responsable de lesions cutanees de type dermatomyosite. Rev Med Int 1990;11 (Suppl 3):4196.
10. Richard M, Truchetet F, Freidel J, Leclech C, Held E. Skin lesions simulating chronic dermatomyositis during long-term hydroxyurea therapy. J Am Acad Dermatol 1989;21:797-9.
11. Kennedy BJ, Smith LR, Goltz RW. Skin changes secondary to hydroxyurea therapy. Arch Dermatol 1975;111:183-7.
12. Thomas L, Ferrier E, Moulin G. Dermatomyositis-like eruption complicating hydroxyurea therapy of myelogenous leukemia. Eur J Dermatol 1992;2:492-5.
13. Velez A, Lopez-Rubio F, Moreno JC. Chronic hydroxyurea-induced dermatomyositis-like eruption with severe dermal elastosis. Clin Exp Dermatol 1998;23:94-5.
14. Varma S, Lanigan SW. Dermatomyositis-like eruption and leg ulceration caused by hydroxyurea in a patient with psoriasis. Clin Exp Dermatol 1999;24:164-6.
15. Kelly R, Bull R, Marsden A. Cutaneous manifestations of long-term hydroxyurea therapy. Australas J Dermatol 1994;35:61-64.
16. Simpson NB, Golding JR. Dermatomyositis induced by penicillamine. Acta Derm Venereol 1979;59:543-4.
17. Fernandez L, Swinson DR, Hamilton EB. Dermatomyositis complicating penicillamine treatment. Ann Rheum Dis 1977;35:94-5.
18. Rodriguez-Garcia JL, Serrano Commino M. Lovastatin-associated dermatomyostitis. Postgrad Med J 1996;72:694.
19. Khattak FH, Morris JM, Branford WA. Simvastatin-associated dermatomyositis. Br J Rheumatol 1994;33:199.
20. Kass E, Straume S, Mellbye OF, Munthe E, Solheim BG. Dermatomyositis associated with BCG vaccination. Scand J Rheumatol 1979;8:187-91.
21. Akiyama C, Osada A, Sou K, Yasaka N, Ohtake N, Furue M, et al. A case of dermatomyositis triggered by tegafur. Acta Derm Venereol 1997;77:490.